Prostate-specific membrane antigen (PSMA)–targeted imaging of metastatic prostate cancer (PCa) via small molecule inhibitors: Comparison to bone scan, CT/MRI, and 111In capromab.
R. E. Coleman
Honoraria - Molecular Insight Pharmaceuticals
Research Funding - Molecular Insight Pharmaceuticals
J. A. Barrett
Employment or Leadership Position - Molecular Insight Pharmaceuticals
Stock Ownership - Molecular Insight Pharmaceuticals
A. Hussain
Research Funding - Molecular Insight Pharmaceuticals
K. M. Slawin
Research Funding - Molecular Insight Pharmaceuticals
T. Armor
Employment or Leadership Position - Molecular Insight Pharmaceuticals
Stock Ownership - Molecular Insight Pharmaceuticals
N. D. LaFrance
Stock Ownership - Molecular Insight Pharmaceuticals
J. W. Babich
Employment or Leadership Position - Molecular Insight Pharmaceuticals
Stock Ownership - Molecular Insight Pharmaceuticals